Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats
| Autor: | Jay Lynn Unangst, SuJean Choi, John D. Fernstrom, Briana DiSilvio |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Drug
Olanzapine Male medicine.medical_specialty Food intake media_common.quotation_subject medicine.medical_treatment Weight Gain General Biochemistry Genetics and Molecular Biology Article Rats Sprague-Dawley Benzodiazepines Eating Pharmacokinetics Blood drug Internal medicine medicine Animals General Pharmacology Toxicology and Pharmaceutics Antipsychotic Clozapine media_common business.industry General Medicine Rats Endocrinology Female medicine.symptom business Weight gain medicine.drug Antipsychotic Agents |
| Zdroj: | Life sciences. 81(12) |
| ISSN: | 0024-3205 |
| Popis: | Many antipsychotics cause weight gain in humans, but usually not in rats, when injected once or twice daily. Since blood antipsychotic half-lives are short in rats, compared to humans, chronic administration by constant infusion may be necessary to see consistent weight gain in rats. Male and female rats were implanted with mini-pumps for constant infusion of olanzapine (5 mg/kg/day), clozapine (10 mg/kg/day) or vehicle for 11 days. Food intake and body weight were measured; blood drug levels were measured by HPLC. Olanzapine increased food intake and body weight in female, but not male rats. Serum olanzapine concentrations were 30-35 ng/ml. Clozapine had no effect on food intake or body weight in female or male rats. Serum clozapine concentrations were about 75 ng/ml. Single-dose pharmacokinetic analysis revealed a serum terminal half-life of 1.2-1.5 h for each drug, with no sex differences. Despite the fact that olanzapine and clozapine promote weight gain in humans, these drugs appear to have minimal effects on body weight and food intake in rats, except for a modest effect of olanzapine in female rats, even though therapeutic levels of olanzapine are achieved in serum during chronic infusion. Hence, the rapid clearance of drug following single administration in previous studies cannot explain the weak or absent effects of antipsychotics on weight gain in this species. The rat thus appears to be an inadequate model of weight gain produced by some antipsychotics in humans. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect